<DOC>
	<DOCNO>NCT01931761</DOCNO>
	<brief_summary>To evaluate absorption , distribution , metabolism excretion ( ADME ) single dose [ 14C ] selumetinib volunteer</brief_summary>
	<brief_title>Study Evaluating Absorption , Distribution , Metabolism Excretion ( ADME ) Single Dose 14C Selumetinib Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent prior study specific procedure . Have body mass index ( BMI ) 18 32 kg/m2 inclusive weigh least 50 kg 100 kg , inclusive . Regular bowel movement ( ie , average production least 1 stool per day ) . Current past history central serous retinopathy retinal vein thrombosis , intraocular pressure great 21 mmHg uncontrolled glaucoma . Exposure radiation level background exceed 5 mSv last 12 month 10 mSv last 5 year . History presence clinically significant disease disorder opinion investigator Any clinically important abnormality clinical chemistry , haematology , urinalysis result , vital sign ECG baseline opinion Investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pharmacokinetics , mass balance , AZD6244</keyword>
</DOC>